Coronary stenting with the Genous™ Bio-engineered R stent™ in elderly patients: 12-month outcomes from the e-HEALING registry

Circulation Journal

Volumn 75, Issue 11, 2011, Pages 2590-2597

  Damman, Peter ^a   Iñiguez, Andres ^b   Klomp, Margo ^a   Beijk, Marcel ^a   Woudstra, Pier ^a   Silber, Sigmund ^c   Ribeiro, Expedito E ^d   Suryapranata, Harry ^e,f   Hian, Kui Sim ^g,h   Tijssen, Jan G P ^a   de Winter, Robbert J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF VIGO   (Spain)

^c Kardiologische Praxis und Praxisklinik   (Germany)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e HOSPITAL DE WEEZENLANDEN   (Netherlands)

^f RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^g MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^h SARAWAK GENERAL HOSPITAL   (Malaysia)

Author keywords

12 month outcomes; e HEALING; Elderly; Genous EPC capturing R stent

Indexed keywords

ANTITHROMBOCYTIC AGENT;

ADULT; AGE; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART DEATH; HEART INFARCTION; HUMAN; IMPLANT REGISTRY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT COMPLIANCE; PROGNOSIS; RETREATMENT; STENT THROMBOSIS; TARGET LESION REVASCULARIZATION; TARGET VESSEL REVASCULARIZATION;

AGE FACTORS; AGED; ANGIOPLASTY, BALLOON, CORONARY; BLOOD VESSEL PROSTHESIS; DEATH; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PRODUCT SURVEILLANCE, POSTMARKETING; REGISTRIES; RISK FACTORS; STENTS; THROMBOSIS; TICLOPIDINE;

EID: 80054880524     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0509     Document Type: Article

References (19)

1. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB III, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 2006; 113: e166-e286.
2. Chauhan MS, Kuntz RE, Ho KL, Cohen DJ, Popma JJ, Carrozza JP Jr, et al. Coronary artery stenting in the aged. J Am Coll Cardiol 2001; 37: 856-862.
3. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, et al. Safety and efficacy of drug-eluting and bare metal stents: Comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198-3206.
4. Inoue T, Node K. Molecular basis of restenosis and novel issues of drug-eluting stents. Circ J 2009; 73: 615-621.
5. Honda Y. Drug-eluting stents: Insights from invasive imaging technologies. Circ J 2009; 73: 1371-1380.
6. Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, Haque G, et al. Clinical effectiveness of coronary stents in elderly persons: Results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. J Am Coll Cardiol 2009; 53: 1629-1641.
7. Groeneveld PW, Matta MA, Greenhut AP, Yang F. Drug-eluting compared with bare-metal coronary stents among elderly patients. J Am Coll Cardiol 2008; 51: 2017-2024.
8. van Werkum JW, Heestermans AA, Zomer AC, Kelder JC, Suttorp MJ, Rensing BJ, et al. Predictors of coronary stent thrombosis: The Dutch Stent Thrombosis Registry. J Am Coll Cardiol 2009; 53: 1399-1409.
9. Park KW, Hwang SJ, Kwon DA, Oh BH, Park YB, Chae IH, et al. Characteristics and predictors of drug-eluting stent thrombosis. Circ J 2011; 75: 1626-1632.
10. Silber S, Damman P, Klomp M, Beijk MA, Grisold M, Ribeiro EE, et al. Clinical results after coronary stenting with the Genous Bioengineered R stent: 12-month outcomes of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry. EuroIntervention 2011; 6: 819-825.
11. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, et al. Acute coronary care in the elderly. Part I: Non-STsegment-elevation acute coronary syndromes: A scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: In collaboration with the Society of Geriatric Cardiology. Circulation 2007; 115: 2549-2569.
12. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, et al. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351.
13. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions: The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-847.
14. Damman P, Klomp M, Beijk MA, Silber S, Grisold M, Ribeiro EE, et al. Twelve-month outcomes after coronary stenting with the Genous Bio-Engineered R Stent in diabetic patients from the e-HEALING Registry. J Interv Cardiol 2011; 24: 285-294.
15. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005; 45: 1441-1448.
16. Vlaar PJ, Lennon RJ, Rihal CS, Singh M, Ting HH, Bresnahan JF, et al. Drug-eluting stents in octogenarians: Early and intermediate outcome. Am Heart J 2008; 155: 680-686.
17. Forman DE, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, et al. Long-term paclitaxel-eluting stent outcomes in elderly patients. Circ Cardiovasc Interv 2009; 2: 178-187.
18. Klomp M, Beijk MA, Varma C, Koolen JJ, Teiger E, Richardt G, et al. 1-year outcome of TRIAS HR (TRI-Stent Adjudication Study-High Risk of Restenosis) a multicenter, randomized trial comparing genous endothelial progenitor cell capturing stents with drug-eluting stents. JACC Cardiovasc Interv 2011; 4: 896-904.
19. Azzarelli S, Galassi AR, Grosso G, Tomasello D, Campisano B, Giacoppo M, et al. Clinical and angiographic outcomes in elderly patients treated with endothelial progenitor cell capture coronary stents: Results from a prospective single-center registry. J Invasive Cardiol 2010; 22: 594-598.